JB
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Woebking, B.
Right arrow Articles by van Veen, H. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Woebking, B.
Right arrow Articles by van Veen, H. W.
Journal of Bacteriology, September 2005, p. 6363-6369, Vol. 187, No. 18
0021-9193/05/$08.00+0     doi:10.1128/JB.187.18.6363-6369.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Drug-Lipid A Interactions on the Escherichia coli ABC Transporter MsbA

Barbara Woebking, Galya Reuter, Richard A. Shilling, Saroj Velamakanni, Sanjay Shahi, Henrietta Venter, Lekshmy Balakrishnan, and Hendrik W. van Veen*

Department of Pharmacology, University of Cambridge, Cambridge CB2 1PD, United Kingdom

Received 26 April 2005/ Accepted 22 June 2005

MsbA is an essential ATP-binding cassette half-transporter in the cytoplasmic membrane of the gram-negative Escherichia coli and is required for the export of lipopolysaccharides (LPS) to the outer membrane, most likely by transporting the lipid A core moiety. Consistent with the homology of MsbA to the multidrug transporter LmrA in the gram-positive Lactococcus lactis, our recent work in E. coli suggested that MsbA might interact with multiple drugs. To enable a more detailed analysis of multidrug transport by MsbA in an environment deficient in LPS, we functionally expressed MsbA in L. lactis. MsbA expression conferred an 86-fold increase in resistance to the macrolide erythromycin. A kinetic characterization of MsbA-mediated ethidium and Hoechst 33342 transport revealed apparent single-site kinetics and competitive inhibition of these transport reactions by vinblastine with Ki values of 16 and 11 µM, respectively. We also detected a simple noncompetitive inhibition of Hoechst 33342 transport by free lipid A with a Ki of 57 µM, in a similar range as the Ki for vinblastine, underscoring the relevance of our LPS-less lactococcal model for studies on MsbA-mediated drug transport. These observations demonstrate the ability of heterologously expressed MsbA to interact with free lipid A and multiple drugs in the absence of auxiliary E. coli proteins. Our transport data provide further functional support for direct LPS-MsbA interactions as observed in a recent crystal structure for MsbA from Salmonella enterica serovar Typhimurium (C. L. Reyes and G. Chang, Science 308:1028-1031, 2005).


* Corresponding author. Mailing address: Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, United Kingdom. Phone: 44-1223-334032. Fax: 44-1223-334040. E-mail: hwv20{at}cam.ac.uk.


Journal of Bacteriology, September 2005, p. 6363-6369, Vol. 187, No. 18
0021-9193/05/$08.00+0     doi:10.1128/JB.187.18.6363-6369.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Appl. Environ. Microbiol. Infect. Immun. Eukaryot. Cell
Mol. Cell. Biol. J. Virol. Microbiol. Mol. Biol. Rev.
ALL ASM JOURNALS

Copyright © 2005 by the American Society for Microbiology. All rights reserved.